The C max of HM3G was 17% lower (ratio to control: 0.83, 90% CI, 0.71-0.97) in the rifampin phase compared with placebo, but this did not reach statistical significance ( P = .0579).
← all excerpts
Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers.
1
0.0579
0.0579